Pharming Group to present at the H.C. Wainwright 27th Annual Global Investment Conference
Pharming Group (Nasdaq: PHAR) announced its participation in the upcoming H.C. Wainwright 27th Annual Global Investment Conference in New York, scheduled for September 8-10, 2025. CEO Fabrice Chouraqui will deliver a presentation on Monday, September 8 at 1:30pm EDT/19:30 CEST.
Investors can access the live webcast and replay through Pharming's website in the "Upcoming Events" and "News" sections. One-on-one meetings with management can be arranged through Investor Relations or H.C. Wainwright representatives.
Pharming Group (Nasdaq: PHAR) ha annunciato la sua partecipazione al 27° H.C. Wainwright Annual Global Investment Conference che si terrà a New York dall'8 al 10 settembre 2025. Il CEO Fabrice Chouraqui terrà una presentazione lunedì 8 settembre alle 13:30 EDT/19:30 CEST.
Gli investitori possono seguire la diretta e la registrazione sul sito di Pharming, nelle sezioni "Upcoming Events" e "News". Incontri individuali con il management possono essere organizzati tramite Investor Relations o i rappresentanti di H.C. Wainwright.
Pharming Group (Nasdaq: PHAR) anunció su participación en la 27ª Conferencia Anual Global de Inversión de H.C. Wainwright en Nueva York, programada del 8 al 10 de septiembre de 2025. El CEO Fabrice Chouraqui ofrecerá una presentación el lunes 8 de septiembre a la 1:30 p.m. EDT/19:30 CEST.
Los inversores podrán acceder a la transmisión en vivo y a la reproducción desde la página web de Pharming, en las secciones "Upcoming Events" y "News". Las reuniones individuales con la dirección pueden concertarse a través de Investor Relations o de los representantes de H.C. Wainwright.
Pharming Group (Nasdaq: PHAR)는 2025년 9월 8일부터 10일까지 뉴욕에서 열리는 H.C. Wainwright 제27회 연례 글로벌 투자 콘퍼런스에 참가한다고 발표했습니다. CEO Fabrice Chouraqui는 9월 8일 월요일 오후 1:30 EDT/19:30 CEST에 발표를 진행합니다.
투자자들은 Pharming 웹사이트의 "Upcoming Events" 및 "News" 섹션에서 라이브 웹캐스트와 다시보기를 이용할 수 있습니다. 경영진과의 일대일 미팅은 Investor Relations 또는 H.C. Wainwright 담당자를 통해安排할 수 있습니다.
Pharming Group (Nasdaq: PHAR) a annoncé sa participation à la 27e conférence annuelle mondiale d'investissement H.C. Wainwright à New York, prévue du 8 au 10 septembre 2025. Le PDG Fabrice Chouraqui donnera une présentation le lundi 8 septembre à 13h30 EDT/19h30 CEST.
Les investisseurs peuvent accéder au webdiffusion en direct et au replay via le site de Pharming, dans les rubriques "Upcoming Events" et "News". Des rendez‑vous individuels avec la direction peuvent être organisés via Investor Relations ou les représentants de H.C. Wainwright.
Pharming Group (Nasdaq: PHAR) hat seine Teilnahme an der 27. H.C. Wainwright Annual Global Investment Conference in New York angekündigt, die vom 8. bis 10. September 2025 stattfindet. CEO Fabrice Chouraqui wird am Montag, den 8. September, um 13:30 Uhr EDT/19:30 Uhr CEST eine Präsentation halten.
Investoren können das Live-Webcast und die Aufzeichnung über die Pharming-Website in den Bereichen "Upcoming Events" und "News" abrufen. Einzelgespräche mit dem Management können über Investor Relations oder die Vertreter von H.C. Wainwright vereinbart werden.
- None.
- None.
Leiden, the Netherlands, September 3, 2025: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) announces that Pharming management will participate in the H.C. Wainwright 27th Annual Global Investment Conference in New York on September 8-10, 2025.
Fabrice Chouraqui, Chief Executive Officer, will present on Monday, September 8 at 1:30pm EDT/19:30 CEST. A live webcast and replay of the presentation can be found in the “Upcoming Events” and “News” sections of Pharming’s website.
For more information about the conference, or to schedule a one-to-one meeting with Pharming’s management team, please contact Investor Relations at investor@pharming.com or your H.C. Wainwright representative.
About Pharming Group N.V.
Pharming Group N.V. (EURONEXT Amsterdam: PHARM/Nasdaq: PHAR) is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. We are commercializing and developing a portfolio of innovative medicines, including small molecules and biologics. Pharming is headquartered in Leiden, the Netherlands, and has employees around the globe who serve patients in over 30 markets in North America, Europe, the Middle East, Africa, and Asia-Pacific.
For more information, visit www.pharming.com and find us on LinkedIn.
For further public information, contact:
Pharming Group, Leiden, the Netherlands
Michael Levitan, VP Investor Relations & Corporate Communications
T: +1 (908) 705 1696
Saskia Mehring, Corporate Communications Manager
T: +31 6 28 32 60 41
FTI Consulting, London, United Kingdom
Simon Conway/Alex Shaw/Amy Byrne
T: +44 203 727 1000
LifeSpring Life Sciences Communication, Amsterdam, the Netherlands
Leon Melens
T: +31 6 53 81 64 27
E: pharming@lifespring.nl
US PR
Ethan Metelenis
T: +1 (917) 882-9038
E: Ethan.Metelenis@precisionaq.com
Attachment
FAQ
When is Pharming Group (PHAR) presenting at the H.C. Wainwright Conference 2025?
How can investors watch Pharming Group's H.C. Wainwright Conference presentation?
Who will be presenting for Pharming Group at the H.C. Wainwright Conference?
How can investors schedule meetings with Pharming Group management at the conference?
